Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 3,201–3,300 of 3,349
Sakakibara, Y., Okahara, K., Kakuta, J., Emoto, K., Ofusa, Y., & Ohba, K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.725945
Kim, J. P., Lee, H., Kim, B.-H., Kang, H., Shin, D., Yim, S., Kim, S., Seo, S. W., & Kim, H.-N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261454540
Supervised deep learning with gene functional annotation for cell classification
Lin, Z.-X., Gao, Y.-Y., & Sun, W. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014327
“Early studies showed that activated microglia cluster around amyloid plaques [32], and later work established a causal mechanism linking microglia activity to synaptic degeneration [29].”
Mi, Y., Yan, H., Dong, S., Liu, Z. F., Zhang, M., Zhao, J., Yan, G., Li, Y., Gao, S., & Wu, Y. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02341-8
“The classical pathway, which involves proteins such as C1q, C3, and C4, has been linked to neuroinflammation and synapse loss in Alzheimer’s disease (AD) [6, 7].”
Early-onset neuroinflammation drives neurodegeneration caused by lysosomal PI(3,5)P2 insufficiency
Wong, B., Payne, M., Silva, A., Kurniawan, E., Eidman, A. S., Pizzo, D. P., Rajupalem, R., Lenk, G. M., Paulo, J. A., Khan, T., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107467
Phosphodiesterase 8 (PDE8), a novel target for neurodegenerative diseases
Zhao, X., Fu, Y.-T., Qiu, N., Pan, Y.-X., Zhang, H., & Wang, H. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112654
Dysregulation of complement at the synapse in P301S mice and human tauopathies
Nimmo, J., Daskoulidou, N., Pottelberge, S. V., Muynck, L. D., & Morgan, B. P. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02347-2
“Complement plays critical roles in driving synapse loss in Alzheimer’s disease (AD) [1–3].”
Concepts, types, and treatment strategies for neurodegenerative disorders
Rana, R., Jaiswal, S., Sethi, M., Tripathi, S., Mishra, K., Gupta, P., & Chourasia, M. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00003-9
Microglia-centered cellular crosstalk in neurodegeneration
Huang, H., & Mass, E. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.06.001
mTORC2-Na v 1.2 signaling drives early hyperexcitability in Alzheimer’s disease mouse model
Dvorak, N. M., & Noebels, J. L. (2026) · Channels · doi:10.1080/19336950.2026.2687246
“Studies of J20 mice also reveal an early decrease in synapse number [19], which, when combined with intrinsic membrane hyperexcitability, synaptic dysfunction, and network hypersynchrony, paint a complex picture of nascent circuit instability in early-stage AD.”
Divergent toxicity mechanisms of amyloid-beta aggregates arising from a single aggregation reaction
Metodieva, V., Marchese, S., Esposito, P., Danial, J. S. H., Falco, A. D., De, S., Klenerman, D., & Varela, J. A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117595
Soni, H., Sutherland, G. T., & Hofer, M. J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03927-8
“synaptic tagging, anaphylatoxin signalling, and terminal pathway activation [16, 95, 99, 112, 117, 120, 176].”
Huang, X., Li, Q., Tao, G., Gan, X., Lu, J., Krasny, S., & Shi, L. (2026) · Aging Cell · doi:10.1111/acel.70607 · Cited by 2
“For example, age-associated activation of microglia in the central nervous system may accelerate the clearance of neuroprotective EVs, thereby limiting their therapeutic persistence and reducing delivery efficiency within the aging brain (Hong et al. 2016).”
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.05
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.references
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.07
Third Section: Design of a dimeric-nanobody specific for Aβ42 oligomers: the Dimeric-DesAb-O
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.06
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.03
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.04
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.02
Conclusion and Future Perspectives
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.08
Yan, C., Chen, Z., Yan, Y., Wang, M., Chen, W., Zhou, F., & Liu, Q. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08414-5
“C1q initiates the classical complement pathway and has been implicated in synapse elimination during development and in AD [28–30].”
Li, X., Tian, X., Zhang, J., Pan, M., Xu, B., Wei, J., Yan, D., & Fang, W. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01605-z
“However, excessive activation of this pathway in disease settings can result in pathological synapse loss [41, 42].”
Li, C., Wang, L., Wang, F., Wang, L., Xu, L. H., Lyu, W., Shan, K., Li, J., Zhou, H., Rong, F., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03921-0
“…and IL-1β disrupt synaptic plasticity [16, 177, 178]; complement proteins C1q and complement component 3 (C3) initiate the classical complement cascade, with C3 deposited on the surface of neurons and serving as an “eat-me” signal that mediates microglial phagocytosis of synapses [124, 179–181].”
Liu, W., Qin, W., Li, Y., & Jia, J. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106888
Huang, P., Jiang, S., Chen, Z., Liu, N., Li, H., Wang, A., Luo, L., Huang, W., Chen, S., & Deng, Y. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.07.003
Li, H., Song, S., Tang, D., Zhu, Y., Zhang, X., Wang, C., Zhang, Y., Du, M., Liu, C., & Hu, Y. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106847
Environmental Pollutants and Neuroinflammation in Alzheimer’s Disease Progression
García-Núñez, A. (2026) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad3030033 · Cited by 1
“This transition shifts their functional role from neuroprotection to the aberrant pruning of viable synapses, further accelerating tissue degradation [17].”
Shan, H., Lu, G., Yuan, Y., Dong, Q., Fang, C., Yu, K., Chen, L., Wei, Z., Chen, H., Hu, L., et al. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6c00231
de Leeuw, D. M., Duits, F. H., Dicks, E., Vromen, E. M., Teunissen, C. E., Barkhof, F., van der Flier, W. M., Visser, P. J., & Tijms, B. M. (2026) · Brain Communications · doi:10.1093/braincomms/fcag257
“24,25,71 74 This is further supported by the observed association of lower small world values and lower levels of SIRPA which is considered to be involved in an anti-phagocytic signal for microglial pruning of synapses.”
Modeling Alzheimer’s disease with brain organoids: mechanisms, applications, and future directions
Zhao, Q., Li, S., Ju, Y., Kong, X., & Liu, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1791272 · Cited by 2
“Hong et al. (2016) provided the first direct evidence that the developmental synaptic pruning pathway is aberrantly reactivated in AD and identified complement proteins and microglia as potential early therapeutic targets.”
Self-citationXiong, X., Wu, Q., Qiu, X., & Ping, S. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150462 · Cited by 1
Pérez-Villavicencio, J., Villa-Robledo, O., Megchun-Vázquez, X., Uriarte-Jiménez, F., Rubio‐Osornio, M., & Serrano‐García, N. (2026) · Neuroglia · doi:10.3390/neuroglia7030023
“Beyond cytokine signaling, microglia play a direct role in shaping neural circuits through activity-dependent synaptic pruning mediated by complement cascade proteins [91,92].”
Mechanisms of autophagy–lysosome pathway impairment in Alzheimer's disease
Lü, K., Lu, Y., Tang, R., Dong, X., Zhuang, P., Gao, Y., Cheng, M., Wang, Y., & Wang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460879
“195 Cluster of differentiation 47 (CD47) binds to signal regulatory protein α (SIRP α ) on microglia to inhibit synaptic phagocytosis.”
Zhang, Y., Wang, Z., Li, G., & Qiao, H. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb00899b
Wang, C., Yun, Q. I., Zhang, Z., Zhao, H., Lin, F., & Cao, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1877167
“NLRP3 in fl ammasome activation has been associated with tau pathology (71), while complement-dependent microglial mechanisms contribute to early synapse loss in AD models (57).”
Rentsch, P., Irving, J., Conn, I., Laloli, K. J., Milham, L. T., Stayte, S., & Vissel, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.05.736610
“Meanwhile, in other neurodegenerative disorders, including Alzheimer’s (AD) 12–14 and Huntington’s disease (HD) 15 , synapse loss has been extensively characterized, and accumulating evidence implicates microglial dysfunction as a key driver of this process.”
Cheung, N. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261468711
Kelley, A., Sackinger, E. D., Frischman, M., Thomas, N. O., Kim, K., Scuderi, G., Labut, E. M., MacMurchy, D., Ikea-Mario, T., Rauenhorst, J., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1804332
“In some rodent models, synaptic transmission impairment precedes plaque deposition (Hermann et al., 2009) and synapse loss mediated by complement and microglia activation also occurs earlier (Hong et al., 2016).”
Plaque-associated microglial polarization in visual brain regions of the 5xFAD mouse model
McCool, S., Jain, A., Smith, J. C., & Hook, M. J. V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1824891 · Cited by 1
“Although their role in A β pathology is unclear, they have been shown to contribute to pathological synaptic pruning in AD and frontotemporal dementia acting as drivers of neurodegeneration (Hong et al., 2016; Lui et al., 2016).”
Infectious vs. Sterile Neuroinflammation: Differential Consequences on Neuronal CircuitryPreprint
Talero-López, D. (2026) · Qeios · doi:10.32388/1h63qt.3
Piłat, D., Baranger, K., & Rivera, S. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.07.004
Su, B., Dong, W., Su, L., Ye, J., Yao, Q., Liu, M., Wu, J., & Du, K. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108344 · Cited by 2
Rumpf, S.-L., Struebing, F. L., Nalbach, K., Vargiu, C. M., Berg, G., Lichtenthaler, S. F., Parchi, P., Gao, P., Weilin, C. H. E. N., Brendel, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74961-6
Wu, P., Liao, Y., Liu, C., Liu, X., Feng, Q., & Cheng, X. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06066-6
“…a clearance paradox: complement can opsonize Aβ for phagocytic handling but can also tag synapses for microglial elimination, implying that shifts in local complement tone—poten-tially influenced by drainage and compartmental retention— may tip the balance from net benefit to net harm [117, 118].”
APP /Aβ Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer's Disease
Jáuregui, G. V., Coomes, S., Emmett, E., Thatcher, A., Oyelakin, N., Čarná, M., Zelinková, J., Novotný, J., Polakova, N., Kuruvilla, T., et al. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70526 · Cited by 1
“This astrocytic APP framework complements, rather than opposes, established neuron-and microglia-centric models of AD (Hardy and Higgins 1992; Hong et al. 2016).”
Banaeyoun, H., Digehsara, Y. S., & Golichenari, B. (2026) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2026.100651
“These inflammatory cascades have been associated with synaptic pruning, cytoskeletal instability, tau phosphorylation, and neuronal stress responses in diverse neuroinflammatory and neurodegenerative experimental systems (Hong et al., 2016).”
He, Z., Ma, J., Liu, Y., & Du, Z. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156752 · Cited by 2
“C3 cleavage is central to complement activation [30,31].”
Brain macrophages in neurodegeneration
Johnston, R. J., Torres, N. A. P., Li, Y., & Han, C. Z. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.06.005 · Cited by 1
The human retina in Alzheimer’s disease: Pathology, mechanisms, and biomarkers
Müller, L. P. D. S., Majumdar, S., & Recio, B. S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103275
Complosome as a key modulator of cellular senescence, aging and age-related diseases
Gold, N. M., Okeke, M. N., Ewhea, A. S., & He, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103274 · Cited by 1
Prasad, U. V., Munikumar, D. M., Vadlamudi, S., Chathyushya, K. B., & Pradeepkiran, J. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36636-9.00007-1
Long non-coding RNAs in glial cells: key drivers of neuroinflammation in cognitive disorders
Malatino, C., Raffaele, I., Quartarone, A., Raciti, G., Anchesi, I., Iraci, N., & Cola, M. C. D. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1849634
“The activation of TLR4 by A β also activates microglia, triggering an increase in cytokines and oxidative stress (Hong et al., 2016), while the downregulation of TLR4 alleviates inflammation (Xu et al., 2020).”
Chu, M., Tan, M., Gan, X., Cui, S., & Shi, L. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06091-5 · Cited by 2
“Microglia shape neural circuits during development and maintain them in adulthood through synaptic pruning [12, 19 ].”
Yang, F., Gao, W., Wang, J. Z., & Li, H. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06098-y
“On the one hand, inflammation-driven MG promote complement-mediated synaptic tagging and phagocytosis, and impaired ALP function hinders the degradation of internalized synaptic substances, leading to abnormal synaptic overpruning [70].”
Du, L., & Yan, J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107556
Brain aging clocks: From methodological advances to cellular mechanisms
Suk, K. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113260
Jiang, Y., Li, Y., Xie, Q., Li, Y., & Wang, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.28.738702
“…work showing that C1q and other complement components rise early in AD models and can localize to synapses before extensive plaque accumulation [45, 46], as well as single-cell studies describing pre-DAM or early activated microglial states with concomitant complement-gene upregulation in…”
Gong, M., Lan, J. X., & Miao, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1908574 · Cited by 3
“…microglial state (Yuan et al., 2016); (ii) complement-mediated synapse elimination, targetable via C1q or C3 blockade to limit maladaptive pruning (Hong et al., 2016); (iii) reactive-astrocyte conversion, where suppression of the neurotoxic (C3 /A1-like) phenotype—e.g., by interrupting IL-1 α…”
Liu, Y., Lu, J., Zhang, Z., Yao, D., Xia, Y., & Chen, K. (2026) · Vision · doi:10.3390/vision10030050
Aditi, Blackwell, T. A., Fang, X., Sharma, S., Mendoza, M., LANDAY, A. L., Golovko, G., & Samir, P. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14017-3
Exploring Endotoxemia in Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy
Larsen, P. P., Linard, M., Schweitzer, C., Delyfer, M., Korobelnik, J., Helmer, C., & Delcourt, C. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.10.14
“118,119 Evidence from complement C3-deficient (cid:129) Mixed linear models: Higher esterified 3-hydroxy fatty acids (a proxy of LPS) were associated with incident thinner retinal nerve fiber layer at baseline (ß = - 1.44, 95 % CI = 2.56–0.33, P = 0.01).”
InfluentialMicroglial CX3CR1 signaling mediates synaptic pruning in degenerative cervical myelopathy
Zhou, C. M., Asgarihafshejani, A., Hong, J., Brockie, S. T., Movahed, M., Sadat, S., Kouhzaei, S., & Fehlings, M. G. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107567
C1q dependency of retinal ganglion cell death in blast-mediated traumatic brain injury
Hedberg‐Buenz, A., Dutca, L. M., Boehme, N., Mann, A., Harper, M. M., Garvin, M. K., & Anderson, M. G. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111192
Zou, Y., Ou, Y., Zhao, H., Chen, G., Chen, Z., Li, Y., & Jiang, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119841 · Cited by 1
Cipriano, G. L., Anchesi, I., Floramo, A., Argento, V., Spinelli, S., Astorino, M. F., Calabrò, M., & Artimagnella, O. (2026) · Cells · doi:10.3390/cells15161433
“Complement proteins of the classical cascade, C1q in particular, are constitutive components of the synaptic cleft and participate in developmental pruning, and their reactivation is detectable at early disease stages, before overt neuronal loss [24,26].”
InfluentialKang, S., & Goodridge, H. S. (2026) · Aging Cell · doi:10.1111/acel.70660
“Complement proteins such as C1q and C3 mark synapses for elimination, and microglia remove these tagged synapses (perhaps sometimes inappropriately), leading to synaptic loss and cognitive decline (Hong et al. 2016; Shi et al. 2017).”
Tarawneh, R. (2026) · Biomedicines · doi:10.3390/biomedicines14081794
“Glycation-induced remodeling of the endothelial glycocalyx perturbs endothelial-glial signaling, leading to astrocytic and mi-https croglial dysregulation and impaired activity-dependent synaptic potentiation [46,47,53].”
InfluentialCorrelation analysis between complement proteins and Alzheimer's disease
Lu, Y.-T., Guo, Z.-M., Liu, M.-Y., Ji, C., Luo, Y., Zhou, S.-Y., Ma, T., Zhu, X.-C., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261475358
“C1q, the initiating molecule of the classical complement pathway, is consistently upregulated in App NL − G − F mice, potentially promoting in fl ammatory feedback loops that lead to neuronal damage and cognitive decline.”
InfluentialThe delta-opioid receptor: a therapeutic target for Alzheimer's disease
Xu, Y., Guan, W., Yang, Y., Yang, Y., Xia, Y., & Peng, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1891339
Lu, Y., Ren, H., Lv, Z., Zhang, T., Zhang, J., & Ren, L. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.143284
Assessing microglial phagocytosis of apoptotic neurons in vitro: a multimodal approach
Mukwaya, A., Yin, Z., Yarcusko, R., Baldwin, G., Uddin, M. N., Venkat, H., Xue, Y., Arnam, N. S. V., Kam, H., Chen, D. F., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1813556
“For example, knockout of pro-engulfment genes C1q and C3 reduced excessive synaptic pruning in a mouse model of AD (Hong et al., 2016).”
Zheng, M., Loers, G., Lin, S., Siebert, H., Wang, Q., Zhang, R., Zheng, X., & Zhang, N. (2026) · Food Frontiers · doi:10.1002/fft2.70346
Jiang, H., Fan, L., He, J., & Zhang, Z. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158720
Liao, P., Zhang, L., Zhang, L., & Hu, Z. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03819-6
Cheng, Z., Bai, R., & Diao, Y. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080828
“Finally, to definitively establish the causal relationship between RGS1 expression, immune cell migration, and synaptic loss, future studies should employ targeted gene silencing or overexpression in primary microglia–neuron co-cultures and transgenic animal models [50].”
Zhang, Z., Tan, H., Shi, F., Dai, J., Ding, W., Li, J., Wang, Y., Yang, R., Xu, X., Chen, C., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71052
Proteomics of aging: biomarkers for physiological systems and diseases
Luo, Y., Xiao, Y.-L., Chen, J.-H., Wang, H., Luo, S., Dong, H., & Huang, R.-P. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1895104
TTN+ macrophages are enriched in the human choroid plexus in Alzheimer’s disease
Bhatta, S., Grzybowski, A., Ortiz, G., & DiStasio, M. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117859
“48– 51 While microglial activation in the parenchyma has been extensively studied, 52,53 the ChP represents an overlooked interface where peripheral immune cells interact with CNS-derived signals.”
Karakurt, H., Yunak, M., Sarı, F. A., & Kökçe, A. (2026) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.1963013
Targeting Microglial Receptors for Alzheimer’s Disease: Translational Barriers from Bench to Bedside
Tang, X., Hasan, I., & Xu, J. (2026) · Neuropharmacology and Therapy · doi:10.15212/npt-2026-0008
Şimşekçi, U., & Cesaretli, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1882211
Cerebral Intramural Cells: A Missing Cellular Link Between Vascular Aging and Alzheimer’s Disease
Arbănași, E. M., Arbănași, E. M., Boghițoiu, T., Cărare, S. A., Cordoș, B. A., Braysh, K., Suciu, N., Chinezu, L., Manu, D. R., Montagne, A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167353
“…of evidence indicate that the A β deposition and NFT are accompanied by sustained activation of innate immune signaling within the CNS, and that complement activation and microglial synaptic pruning can precede measurable parenchymal proteinopathy and contribute to early synaptic dysfunction [134].”
Li, X., Li, L., Liu, X., Liu, S., Yang, W., Gao, J., Kang, S., Wang, L., Li, J., Wang, X., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1865721
Neurodegeneration as a dysregulation of neuroimmune crosstalk
Bennett, F. C., Hong, S. Y., Jiang, N. J., & Marazzi, I. (2026) · Cell · doi:10.1016/j.cell.2026.07.015 · Cited by 3
“In this sense, microglia are not passive bystanders but one of the immunologic concauses of disease, capable of nucleating amyloid pathology in mice, 67 driving synapse loss, 47 and amplifying neuroinflammation 76 (Figure 2).”
Self-citationXu, L., Zhang, Y., Jiang, L., Xing, J. F., Hu, J., Lan, T., & Ta, G. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1902577
“In mouse models of AD, the C1q–C3–CR3 axis contributes to synapse loss before overt plaque formation (Hong et al., 2016).”
InfluentialMago, H. C., Besin, V., Prodjohardjono, A., Vidyanti, A. N., Ervina, W. F., Humardani, F. M., & Mulyanata, L. T. (2026) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2603346
Controversies in dementia research
Spires‐Jones, T. L. (2026) · Oxford University Press eBooks · doi:10.1093/9780198995296.003.0007
The neuroscience of Alzheimer’s disease
Spires‐Jones, T. L. (2026) · Oxford University Press eBooks · doi:10.1093/9780198995296.003.0003
Riluzole shifts glial responses to protect synapses and memory in Aβ oligomer–treated rats
Min-Kaung-Wint-Mon, Kida, H., Kimura, R., & Mitsushima, D. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03972-3
“Both excitotoxic stress and Aβ accumulation upregulate C3 expression and amplify neuroinflammatory signaling [65, 69].”
Valladares, K. N., Fields, J. L., Katz, J., Michalek, S. M., & Zhang, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177665
“Complement components such as C1q and C3 are upregulated in AD brains, where they can tag synapses for microglial elimination, a physiological process that becomes pathological under sustained activation [21,22].”
Alzheimer’s Disease (AD) as a Synaptic Failure
Knafo, S. (2026) · Oxford University Press eBooks · doi:10.1093/9780197851494.003.0581
Fan, W., Han, S., Wang, C., & Gao, J. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02568-z
“…programs in AD, consistent with evidence implicating complement activation and complement-mediated synaptic dysregulation in AD biology (Hong et al. 2016; Papavergi et al. 2025), whereas the POD-related profile was more dominated by metabolic and inflammatory/stress-related pathways.”
Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity
Rentsendorj, A., Vit, J., Hutton, A., Koronyo, Y., Shahin, S., Robinson, E., Barrón, E., Rodriguez, A., Jallow, O., Sheyn, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202600020
“Dysregulated innate immune processes, rather than simply responding to neuronal injury, directly contribute to synaptic dysfunction, circuit destabilization, and disease progression [ 58, 60–65 ].”
Key circuits through which sleep affects memory and their role in Alzheimer's disease
Shen, B., Zhu, Z., Qing, H., & Quan, Z. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261479999 · Cited by 2
“177 Tau oligomers similarly drive pathological phagocytosis by microglia.”
Cao, X., Liu, Y., Ding, M., Zhang, C., Gao, S., Chen, H., & Deng, C. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103643 · Cited by 1
Engram cell vulnerability in neurodegeneration: from mechanistic insights to therapeutic horizons
Bai, Q., Yan, Y., Zeng, C., Li, X., Zeng, G., Saidova, A., Li, H., & Qing, H. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1873893
“In AD, A β oligomers and hyperphosphorylated tau activate microglia and increase complement components such as C1q/C3, which label hippocampal engram synapses for pruning (Wang et al., 2020; Hong et al., 2016).”
Developmental brain programmes and biomarker activation in Alzheimer’s disease
Pini, L., Margoni, M., Filippi, M., & Imbimbo, B. P. (2026) · Brain Communications · doi:10.1093/braincomms/fcag337 · Cited by 1
“26 This is often described purely as pathology.”
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.